Aclaris Therapeutics ACRS
NASDAQ ACRS
$3.87 +0.10 (+2.52%)
As of: Oct 21, 2026 · 10:07 AM EDT

Aclaris Therapeutics (ACRS) Total Debt (2018 - 2021)

Updated

Analysis

Aclaris Therapeutics (ACRS) Total Debt (2018 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,133.43 Bn 1,102.02 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 615.31 Bn 533.83 Bn 17.26 Bn 49.04 Bn
3 AbbVie 505.93 Bn 479.05 Bn 12.70 Bn 70.82 Bn
4 Merck 367.07 Bn 321.44 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.59 Bn 235.28 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.28 Bn 191.68 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 190.31 Bn 164.51 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.69 Bn 117.33 Bn 10.94 Bn 63.19 Bn
10 Aclaris Therapeutics 551.68 Mn 168.04 Mn 1.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 10.73 Mn
Mar 31, 2021 10.69 Mn
Dec 31, 2020 10.65 Mn
Sep 30, 2020 10.61 Mn
Jun 30, 2020 10.57 Mn
Mar 31, 2020 10.57 Mn
Sep 30, 2019 29.93 Mn
Jun 30, 2019 29.92 Mn
Mar 31, 2019 29.92 Mn
Dec 31, 2018 29.91 Mn
API Access

Aclaris Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ACRS&period=max&api_key=YOUR_API_KEY